I. Reile et al. / Tetrahedron 70 (2014) 3608e3613
3611
4. Experimental section
4.1. General remarks
4.2.2.2. 4-(Benzyloxymethyl)cyclopentane-cis-1,2-diol
1i. Compound 1i was prepared by the general dihydroxylation
procedure over 2 days (868 mg, 98%) as a 1:2.8 mixture of di-
astereomers. The preceding cyclopentene was prepared from 3-
cyclopentene carboxylic acid according to a known procedure.41
Compound 1i was obtained as a white crystalline material with
spectral and physical properties matching literature values.42
All reagents purchased from common suppliers were used
without further purification. All solvents were distilled according
to common procedures prior to use. Silica gel 40e100 mm was used
for column chromatography. All NMR spectra were measured at
room temperature on a Bruker Avance III 400 MHz instrument. MS
(EI) spectra were obtained on a Shimadzu GCMS-QP2010 spec-
trometer, FT-IR spectra were recorded on a PerkineElmer Spec-
trum BX spectrometer, HRMS (APCI-MS) measurements were
performed on an Agilent Technologies 6450 UHD Accurate-Mass
Q-TOF LC/MS instrument. Single crystal X-ray diffraction data
were collected on a Bruker SMART X2S. The Supplementary data
contains additional synthetic procedures for the preparation of
oxidation substrates, NMR spectra and the crystallographic data
for this paper (compounds 4j and 4k, deposited with the Cam-
bridge Crystallographic Data Centre (CCDC 833165 (4j) and 833166
(4k))).
4.2.2.3. 4-(tert-Butoxymethyl)cyclopentane-cis-1,2-diol
1j. Compound 1j was obtained by the general dihydroxylation
procedure over 3 days (467 mg, 62%) as a colourless oil (1:2.5
mixture of diastereomers). Major diastereomer: 1H NMR
(400 MHz, CDCl3):
d
¼4.08e4.04 (m, 2H, H1, H2), 3.91 (broad s, 2H,
2ꢂOH), 3.17 (d, J¼6.3 Hz, 2H, eCH2Oe), 2.48e2.37 (m, 1H, H4),
1.89e1.79 and 1.62e1.56 (m, 2ꢂ2H; H3, H5), 1.16 (s, 9H, t-Bu). 13
C
NMR (100 MHz, CDCl3):
d
¼73.7 (C1, C2), 72.2 (eC(CH3)3), 65.8
(eCOHe), 34.7 (C4), 34.4 (C3, C5), 27.4 (t-Bu). Minor diastereomer:
1H NMR (400 MHz, CDCl3):
d
¼3.91 (broad s, 4H, 2ꢂOH, H1, H2),
3.31 (d, J¼3.4 Hz, 2H, eCH2Oe), 2.31e2.23 (m, 1H, H4), 2.07e2.00
and 1.53e1.47 (m, 2ꢂ2H, H3, H5), 1.21 (s, 3.6H, t-Bu0). 13C NMR
(100 MHz, CDCl3):
d
¼74.0 (C1, C2), 73.5 (eC(CH3)3), 64.3 (eCOHe),
33.9 (C4), 33.5 (C3, C4), 27.3 (t-Bu). IR: 3405, 2973, 1391, 1363,
1200, 1083, 1021 cmꢁ1; MS (EI): m/z¼188, 173, 155, 131, 113, 102, 97,
83, 69, 57. APCI-MS: m/z observed 192.1145, calcd for C7H14O3
192.1150.
4.2. Preparation of oxidation substrates
Diols 1b and 1l were purchased from Aldrich. The preparation of
diols 1a and 1ceg was described earlier.31,40 Diols 1hek were
prepared from their preceding cyclopentenes by the general dihy-
droxylation procedure described below. The preparation of the
above mentioned cyclopentenes is described in the Supplementary
data. The preparation of diols 1m, 1n, 5 and alcohol 6 is described in
the Supplementary data.
4.2.2.4. 4-(Methoxymethyl)cyclopentane-cis-1,2-diol
1k. Compound 1k was obtained by the general dihydroxylation
procedure over 2 days (325 mg, 56%) as a colourless oil (1:0.4
mixture of diastereomers). Major diastereomer: 1H NMR (400 MHz,
CDCl3):
d
¼4.09 (t, J¼4.8 Hz, 2H, H1, H2), 3.33 (s, 3H, OMe), 3.23 (d,
J¼6.5 Hz, 2H, eCH2OMe), 2.54 (tt, J¼9.2, 6.5 Hz, 1H; H4), 1.88e1.81
(m, 2H, H3, H5), 1.64e1.57 (m, 2H, H3, H5). 13C NMR (100 MHz,
4.2.1. General procedure for the dihydroxylation of cyclopentenes
used for the preparation of diols 1hek. Corresponding cyclopentene
(4 mmol) was dissolved in 13 mL of 3:1 mixture of t-BuOH and
water. 1.1 mL of 50% w/w aqueous NMO solution (5.2 mmol) and
13.5 mg of 7.5% solid supported OsO4 catalyst (0.004 mmol) were
added. The mixture was stirred at 60 ꢀC until no more of the cor-
responding cyclopentene was observed in the reaction mixture.
The catalyst was filtered off, 20 mL of EtOAc was added and the
mixture was washed with 10 mL of 10% Na2S2O3. The aqueous
phase was separated and extracted with EtOAc. All organics were
combined and dried over MgSO4, the solvent was evaporated and
the product was purified by column chromatography over silica gel.
CDCl3):
d
¼77.3 (eCH2OMe), 73.9 (C1, C2), 58.8 (OMe), 34.6 (C3, C5),
34.5 (C4). Minor diastereomer: 1H NMR (400 MHz, CDCl3):
d¼3.92
(q, J¼5.5 Hz, 2H, H1, H2), 3.40 (s, 3H, OMe), 3.34 (d, J¼4.0 Hz, 2H,
eCH2OMe), 2.30e2.20 (m, 1H, H4), 2.10e2.02 (m, 2H, H4, H5), 1.51
(dt, J¼13.9, 5.5 Hz, 2H, H4, H5). 13C NMR (100 MHz, CDCl3):
¼76.4
d
(eCH2OMe), 74.1 (C1, C2), 59.1 (OMe), 34.2 (C5), 34.0 (C3, C4). IR:
3396, 2930, 1442, 1388, 1338, 1115, 927 cmꢁ1; MS (EI): m/z¼146,
128, 114, 101, 96, 83, 69, 55, 45. APCI-MS: m/z observed 146.0942,
calcd for C7H14O3 146.0943.
4.2.2.5. (1S,2S,3R)-3-(2-(Benzyloxy)ethyl)cyclopentane-trans-1,2-
diol 1m. Compound 1m was obtained as white crystals (186 mg,
20%), mp 34e35 ꢀC. 1H NMR (400 MHz, CDCl3):
d
¼7.33e7.25 (m,
4.2.2. Characterization of the prepared diols 1
4.2.2.1. 3-Benzylcyclopentane-cis-1,2-diol 1h. Compound 1h was
obtained by the general dihydroxylation procedure over 3 days
(711 mg, 93%) as a 1:0.6 mixture of diastereomers (white crystals,
mp 46e47 ꢀC). Major diastereomer: 1H NMR (400 MHz, CDCl3):
5H, Ph), 4.50 (s, 2H, Bn), 4.05 (tt, J¼4.3, 2.3 Hz, 1H, H1), 3.89 (dd,
J¼5.3, 2.3 Hz, 1H, H2), 3.61e3.56 (m, 1H, CH2CH2OBn), 3.49e3.42
(m, 1H, CH2CH2OBn), 2.18e2.03 (m, 2H, H3, H5), 1.88e1.77 (m, 2H,
H4, CH2CH2OBn), 1.69e1.61 (m, 1H, CH2CH2OBn), 1.48e1.33 (m,
d
¼7.31e7.16 (m, 5H, Ph), 4.07 (dd, J¼8.8, 5.3 Hz, 1H, H1), 3.64 (t,
2H, H4, H5). 13C NMR (100 MHz, CDCl3):
127.8 (Ph), 127.8 (Ph), 79.7 (C2), 79.0 (C1), 73.4 (Bn), 70.1
d
¼137.9 (Ph), 128.5 (Ph),
J¼5.6 Hz, 1H, H2), 2.88 (dd, J¼13.5, 6.3 Hz, 1H, Bn), 2.59 (dd, J¼13.5,
8.5 Hz, 1H, Bn), 2.42 (broad s, 1H, OH1), 2.25e2.16 (m, 2H, H3, OH2),
2.01e1.82 (m, 2H, H4, H5), 1.68e1.57 (m, 1H, H5), 1.25e1.14 (m, 1H,
(eCH2CH2OBn), 41.0 (C3), 31.7 (C5), 29.4 (eCH2CH2OBn), 28.3 (C4);
(assignment of diastereomers based on
g-syn effect between
H4). 13C NMR (100 MHz, CDCl3):
d¼140.8 (Ph), 129.0 (Ph), 128.6
C2eOH and eCH2CH2OBn groups when comparing 13C chemical
shifts of compounds 1m and 1n). IR: 3375, 2937, 1454, 1364, 1095,
956, 738, 698 cmꢁ1; MS (EI): m/z¼236, 218, 200, 174, 156, 145, 127,
107, 91. APCI-MS: m/z observed 236.1412, calcd for C14H20O3
236.1412.
(Ph), 126.2 (Ph), 78.9 (C2), 73.0 (C1), 45.5 (C3), 39.8 (Bn), 30.4 (C5),
26.5 (C4). Minor diastereomer: 1H NMR (400 MHz, CDCl3):
d
¼7.31e7.16 (m, 5H, Ph), 4.16e4.10 (m, 1H, H1), 3.83 (t, J¼4.0 Hz,1H,
H2), 2.92 (dd, J¼13.5, 7.9 Hz, 1H, Bn), 2.66 (dd, J¼13.6, 7.6 Hz, 1H,
Bn), 2.42 (broad s, 1H, OH2), 2.34 (broad s, 1H, OH1), 2.14e2.02 (m,
1H, H3), 2.01e1.82 (m, 1H, H5), 1.68e1.57 (m, 3H, H4, H5). 13C NMR
4.2.2.6. (1S,2S,3S)-3-(2-(Benzyloxy)ethyl)cyclopentane-trans-1,2-
(100 MHz, CDCl3):
d
¼141.6 (Ph), 128.9 (Ph), 128.5 (Ph), 125.9 (Ph),
diol 1n. Compound 1n was obtained as a colourless oil (77 mg,
74.7 (C1), 74.3 (C2), 44.3 (C3), 36.0 (Bn), 30.9 (C5), 27.3 (C4). IR:
3409, 2924, 1604, 1495, 1453, 1341, 1100, 1038, 752, 701 cmꢁ1; MS
(EI): m/z¼192, 174, 156, 145, 130, 117, 91, 83. Anal. Calcd for C7H14O3:
C, 74.97; H, 8.39. Found: C, 74.95; H, 8.44.
9%). 1H NMR (400 MHz, CDCl3):
d
¼7.36e7.25 (m, 5H, Ph), 4.50 (s,
2H, Bn), 3.95 (q, J¼7.3 Hz, 1H, H1), 3.60e3.55 and 3.53e3.49 (m,
2H, eCH2CH2OBn), 3.48e3.43 (m, 1H, H2), 1.98e1.89 (m, 1H, H5),
1.87e1.68 (m, 3H, H3, H4, eCH2CH2OBn), 1.64e1.57 (m, 1H,